Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30 + anaplastic B-cell subtypes exhibit distinct clinical features

Brigitte Maes(KU Leuven), C. De Wolf‐Peeters(KU Leuven), A. Anastasopoulou(European Organisation for Research and Treatment of Cancer), Ruth Achten(Jessa Hospital), Ivana Teodorović, Antonino Carbone(Centro di Riferimento Oncologico), Hanneke C. Kluin‐Nelemans(University Medical Center Groningen)
Annals of Oncology
June 1, 2001
10.1023/a:1011195708834
Cited by 32

Related Papers

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
|Blood|2007|971
ALK+ lymphoma: clinico-pathological findings and outcome.
|PubMed|1999|569
Oxidative Stress and Oval Cell Accumulation in Mice and Humans with Alcoholic and Nonalcoholic Fatty Liver Disease
|American Journal Of Pathology|2003|448
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
|Blood|2001|319
ALK Expression Defines a Distinct Group of T/Null Lymphomas (“ALK Lymphomas”) with a Wide Morphological Spectrum
|American Journal Of Pathology|1998|275